• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Hemorrhage/Bleeding (1888); Thromboembolism (2654); Hemorrhagic Stroke (4417)
Event Date 01/18/2022
Event Type  Injury  
Event Description
It was reported that the patient presented with persistent low flows ~1.8-2-2.Echo obtained revealed a large clot in aortic root which is likely causing low flows.The patient has been maintained off anticoagulation due to cerebellar hemorrhage and has 50-60 percent compression of outflow graft.Submitted log file captured multiple low flow events on (b)(6) 2022.The calculated flow appears to have fluctuated below the alarm threshold of 2.5 lpm.Additional information requested but not provided.Related manufacturer report number 2916596-2021-01177.
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer's investigation is completed.
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer's investigation is completed.
 
Event Description
It was reported that the patient presented with persistent low flows ~1.8-2-2.Echo obtained revealed a large clot in aortic root which is likely causing low flows.The patient has been maintained off anticoagulation due to cerebellar hemorrhage and has 50-60 percent compression of outflow graft.Submitted log file captured multiple low flow events on (b)(6) 2022.The calculated flow appears to have fluctuated below the alarm threshold of 2.5 lpm.Additional information requested but not provided.Related manufacturer report number 2916596-2021-01177.
 
Manufacturer Narrative
Initial report added related manufacturer reference # 2916596-2021-01177 on b5 to refer to previous report related to the compression of the outflow graft previously reported in feb2021.Manufacturer's investigation conclusion: review of the submitted log files confirmed low flow alarms.Although a specific cause for the low flow alarms could not be conclusively determined, it was reported by the account that the patient had a clot in the aortic root which was believed to have contributed to the low flow events.A direct correlation between the device and the reported cerebellar hemorrhage and aortic root clot could not be conclusively established through this evaluation.The submitted system controller event log file captured intermittent low flow alarms on (b)(6) 2022.No notable alarms or events were captured.The pump appeared to operate as intended at the set speed.The patient remains ongoing on heartmate 3 left ventricular assist system (lvas), serial number (b)(6).No further related events have been reported at this time.The heartmate 3 lvas instructions for use (ifu), rev.C, is currently available.Section 1, "introduction," lists stroke, bleeding, and thromboembolism as adverse events that may be associated with the use of heartmate 3 lvas.Although the infection reported was deemed to not be device-related, infection is also listed as an adverse event.Section 4, ¿system monitor,¿ explains that the low flow hazard alarm occurs when pump flow is less than 2.5 liters per minute (lpm).A 10-second delay is imposed between the detection of the low flow status and the activation of the associated audio and visual indicators on the system controller.Changes in patient conditions can result in low flow.Section 6, ¿patient care and management¿ (under ¿anticoagulation¿), provides the recommended anticoagulation regimen, including international normalized ratio (inr) range, as well as suggested anticoagulation modifications.Section 7, ¿alarms and troubleshooting,¿ explains all system alarms and the recommended actions associated with them.The heartmate 3 lvas patient handbook, rev.D, also outlines all system controller alarms, as well as how to respond to each alarm condition.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key13524193
MDR Text Key286019456
Report Number2916596-2022-00459
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/14/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/21/2022
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number6935865
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/27/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/04/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age65 YR
Patient SexFemale
Patient Weight68 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-